Himadri Speciality Chemical Limited

NSE:HSCL.NS

661.65 (INR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 12,004.111,769.510,525.110,045.29,509.110,28910,373.910,589.110,466.48,331.9727,724.96,452.95,397.55,653.9124,668.13,892.42,578.73,522.8214,297.34,871.95,244.75,846.8095,9086,194.46,274.23,657.4453,371.13,143.73,460.8
Cost of Revenue 8,941.68,925.77,544.57,245.97,008.67,810.48,201.48,2228,310.26,834.4946,309.25,166.74,239.64,340.6923,392.82,717.41,9412,514.2393,188.53,220.23,349.43,879.3293,730.94,185.34,243.53,058.3742,716.52,812.42,926.8
Gross Profit 3,062.52,843.82,980.62,799.32,500.52,478.62,172.52,367.12,156.21,497.4781,415.71,286.21,157.91,313.221,275.31,175637.71,008.5821,108.81,651.71,895.31,967.482,177.12,009.12,030.7599.071654.6331.3534
Gross Profit Ratio 0.2550.2420.2830.2790.2630.2410.2090.2240.2060.180.1830.1990.2150.2320.2730.3020.2470.2860.2580.3390.3610.3370.3690.3240.3240.1640.1940.1050.154
Reseach & Development Expenses 0320.638000307.14300058.50300049.49300054.5700040.7260000000
General & Administrative Expenses 00000000000000000000000000000
Selling & Marketing Expenses 00000000000000000000000000000
SG&A 1,315.71,168.41,009.8928.4943.7972.3870.71,081.11,210.7961.2772.4736.5618.7238.75188.4188186.8246.506184.8197.9169.7214.282156.8137.6140.80000
Other Expenses 126.4123.9101.998.2101.2105.576.781.915.633.4915.924.112.2-90.66141.351.126.34.074297.965-31.781116.915.620.3761.769434.3168.6136.9
Operating Expenses 1,315.71,168.41,331.71,334.91,240.31,346.21,2521,526.41,4301,132.9411,061.61,110.6918.91,020.93984.6835.9720.8639.812851.2880.9762717.575744.9797.3745.1761.769434.3168.6136.9
Operating Income 1,746.81,675.41,708.51,534.41,320.31,237.9997.2922.6726.2364.6319.9175.6239292.29290.7339.1-83.1368.77257.6770.81,133.31,249.9051,432.21,211.81,285.6-162.698220.3162.7397.1
Operating Income Ratio 0.1460.1420.1620.1530.1390.120.0960.0870.0690.0440.0410.0270.0440.0520.0620.087-0.0320.1050.060.1580.2160.2140.2420.1960.205-0.0440.0650.0520.115
Total Other Income Expenses Net 40-18.1-207-143.4-131.5-132-202.5-499.7-247.2-399.1-47-52.7-65.6-49.277-26.4-38.7-79-279.218-87.4-130-92.4-174.828-56.8-159.7-166.8266.854-480.1271.4-654.7
Income Before Tax 1,786.81,657.31,501.51,3911,188.81,105.9794.7422.9479-34.547272.9122.9173.4243.013264.3300.4-162.189.552170.2640.81,040.91,075.0771,375.41,052.11,118.8104.156-259.8434.1-257.6
Income Before Tax Ratio 0.1490.1410.1430.1380.1250.1070.0770.040.046-0.0040.0350.0190.0320.0430.0570.077-0.0630.0250.040.1320.1980.1840.2330.170.1780.028-0.0770.138-0.074
Income Tax Expense 559505.5413.7384.8327.8343.8142.664.193.456.00529.929.328.914.951100.193.8-35.9-620.23912.2189.9306327.922378.5320.3352.3-14.764-99.8106.4-56.7
Net Income 1,226.21,151.6161,088.21,006.4861.5762.573651.9359.3386-73.035243.394.1145.1228.376164.8206.6-125.6708.163159.2451.6735.8747.338997.1732766.5127.579-160327.7-200.9
Net Income Ratio 0.1020.0980.1030.10.0910.0740.0630.0340.037-0.0090.0310.0150.0270.040.0350.053-0.0490.2010.0370.0930.140.1280.1690.1180.1220.035-0.0470.104-0.058
EPS 2.482.412.472.291.991.81.550.860.92-0.180.580.220.350.540.390.49-0.31.680.381.081.761.772.381.751.830.3-0.410.85-0.52
EPS Diluted 2.482.412.472.291.991.81.550.860.92-0.180.580.220.350.540.390.49-0.31.680.381.081.751.772.381.751.830.3-0.410.85-0.52
EBITDA 1,876.11,801.51,835.71,658.71,441.31,361.11,125.71,053.3731.6382.071483321.6372.5396.238449.2508.558.5309.579380.3867.61,285.61,222.4871,637.61,316.31,389.7241.641123.7686.5138.1
EBITDA Ratio 0.1560.1530.1740.1650.1520.1320.1090.0990.070.0460.0630.050.0690.070.0960.1310.0230.0880.0880.1780.2450.2090.2770.2120.2210.0660.0370.2180.04